Author

Upasana Baskey

Observed name: Upasana Baske

Institutions: Indian Council of Medical Research, National Institute of Cholera and Enteric Diseases

Observed institutions: Indian Council of Medical Research, National Institute of Cholera and Enteric Diseases

ORCID: 0000-0001-6363-886X

Observed ORCID: 0000-0001-6363-886X

OpenAlex ID: A5083060351

Changing pattern of circulating dengue serotypes in the endemic region: An alarming risk to the healthcare system during the pandemic

2023 · Priya Verma, Upasana Baskey, et al. · Journal of Infection and Public Health · 30

Geographic information system-aided evaluation of epidemiological trends of dengue serotypes in West Bengal, India

2024 · Upasana Baskey, Priya Verma, et al. · International Journal of Microbiology Research · 14

Clinicopathological alteration of symptoms with serotype among dengue infected pediatric patients

2022 · Priya Verma, Sayan Banerjee, et al. · Journal of Medical Virology · 10

Assessment of direct-acting antiviral treatment outcomes in patients with chronic hepatitis C infected with various HCV genotypes: Insights from a real-world cohort in West Bengal, India

2025 · Supradip Dutta, Shreyasi Nath, et al. · BMC Infectious Diseases · 2

Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India

2025 · Sagnik Bakshi, Partha Chattopadhyay, et al. · Viruses · 2

Molecular Characterization of Dengue Viruses during an Outbreak in Kolkata: A Hospital-Based Study

2022 · Kheya Mukherjee, Rehena Sarkar, et al. · Medical Journal of Dr D Y Patil Vidyapeeth · 2

Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India

2025 · Sagnik Bakshi, Supradip Dutta, et al. · BMC Infectious Diseases · 1

Differential Proteomic Profiling of Responders and Non-responders to Direct-Acting Antivirals Treatment in Chronic Hepatitis C Virus Infection

2026 · Shreyasi Nath, Anwesha Ghosh, et al. · Journal of Proteome Research

Emergence of HCV genotype 6 and its new variants among intravenous drug users in Manipur, a north-eastern state of India

2025 · Raina Das, Supradip Dutta, et al. · Therapeutic Advances in Infectious Disease

Authors’ response

2024 · Upasana Baskey, Priya Verma, et al. · The Indian Journal of Medical Research

Identifying mutations conferring resistance to Sofosbuvir in DAA naive Genotype 3a isolates from HCV-infected patients in Kolkata, West Bengal

2023 · Raina Das, Moumita Majumdar, et al. · Journal of Clinical and Experimental Hepatology

Molecular Epidemiology of Hepatitis C Virus Infection and Evaluation of the Outcome of Direct Acting Antivirals Treatment in Patients with Chronic Liver Disease in West Bengal, India

2023 · Shreyasi Nath, Supradip Dutta, et al. · Journal of Clinical and Experimental Hepatology

Liver Pays Dengue Toll in Body Along with Wide Range of Gastrointestinal Complications Strongly Associated with DENV Serotype 2 Infection in Children

2022 · Priya Verma, Upasana Baskey, et al. · Journal of Clinical and Experimental Hepatology

Comparative Study on Genomic Diversity of Hepatitis C Virus among High Risk Group (HRG) Individuals in the North-Eastern State of Manipur, India

2022 · Raina Das, Supradip Dutta, et al. · Journal of Clinical and Experimental Hepatology

Works count: 14

Citation count: 61

H-index: 3

I10-index: 3